Hereditary and familial colon cancer - PubMed (original) (raw)

Review

Hereditary and familial colon cancer

Kory W Jasperson et al. Gastroenterology. 2010 Jun.

Abstract

Between 2% to 5% of all colon cancers arise in the setting of well-defined inherited syndromes, including Lynch syndrome, familial adenomatous polyposis, MUTYH-associated polyposis, and certain hamartomatous polyposis conditions. Each is associated with a high risk of colon cancer. In addition to the syndromes, up to one-third of colon cancers exhibit increased familial risk, likely related to inheritance. A number of less penetrant, but possibly more frequent susceptibility genes have been identified for this level of inheritance. Clarification of predisposing genes allows for accurate risk assessment and more precise screening approaches. This review examines the colon cancer syndromes, their genetics and management, and also the common familial colon cancers with current genetic advances and screening guidelines.

PubMed Disclaimer

Figures

Figure 1

Figure 2

The figure illustrates how many genetic variants play both overlapping and different roles in different clinical and genetic settings. There are also multiple gene-gene and gene environmental interactions in these categories.

Cited by

Diet-Wide Association, Genetic Susceptibility and Colorectal Cancer Risk: A Prospective Cohort Study.
Jin D, Lu Y, Wu W, Jiang F, Li Z, Xu L, Zhang R, Li X, Chen D. Jin D, et al. Nutrients. 2023 Nov 16;15(22):4801. doi: 10.3390/nu15224801. Nutrients. 2023. PMID: 38004195 Free PMC article.
Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
Mao D, Zhang Y, Lu H, Fu X. Mao D, et al. Tumour Biol. 2013 Oct;34(5):2529-38. doi: 10.1007/s13277-013-0760-9. Epub 2013 Jul 16. Tumour Biol. 2013. PMID: 23857281
The Rare Diagnosis of Synchronous Breast and Colonic Cancers: A Case Report and Review of Literature.
Asaad A, Barron M, Rasheed N, Idaewor P, Saad Abdalla Al-Zawi A. Asaad A, et al. Cureus. 2021 Feb 12;13(2):e13314. doi: 10.7759/cureus.13314. Cureus. 2021. PMID: 33738159 Free PMC article.
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.
Solier S, Zhang YW, Ballestrero A, Pommier Y, Zoppoli G. Solier S, et al. Curr Cancer Drug Targets. 2012 May;12(4):356-71. doi: 10.2174/156800912800190901. Curr Cancer Drug Targets. 2012. PMID: 22385513 Free PMC article. Review.
Genetic and epigenetic traits as biomarkers in colorectal cancer.
Berg M, Søreide K. Berg M, et al. Int J Mol Sci. 2011;12(12):9426-39. doi: 10.3390/ijms12129426. Epub 2011 Dec 16. Int J Mol Sci. 2011. PMID: 22272141 Free PMC article. Review.

References

1. Lichtenstein P, et al. Environmental and heritable factors in the causation of cancer. New England Journal of Medicine. 2000;343:78–85. - PubMed
1. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124(6):1574–94. - PubMed
1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919–32. - PubMed
1. Hampel H, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783–8. - PMC - PubMed
1. Stoffel E, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009;137(5):1621–7. - PMC - PubMed

Hereditary and familial colon cancer - PubMed (original) (raw)